Klaus P. Hoeflich

机构：Pivot, Neoleukin Therapeutics (United States) · ORCID：0009-0008-8801-2765

发表论文 279 篇 · 总被引 11704 次 · h-index 48

代表论文

• Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies (2026 · Nature Reviews Drug Discovery · 被引 1)
• Supplementary Table 6 from The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers (2026)
• Supplementary Table 1 from The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers (2026)
• Supplementary Table 7 from The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers (2026)
• Supplementary Tables 2-5 from The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers (2026)
• Supplementary Table 10 from The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers (2026)